Tocotrienol-rich fraction prevents cell cycle arrest and elongates telomere length in senescent human diploid fibroblasts

J Biomed Biotechnol. 2011:2011:506171. doi: 10.1155/2011/506171. Epub 2011 Mar 30.

Abstract

This study determined the molecular mechanisms of tocotrienol-rich fraction (TRF) in preventing cellular senescence of human diploid fibroblasts (HDFs). Primary culture of HDFs at various passages were incubated with 0.5 mg/mL TRF for 24 h. Telomere shortening with decreased telomerase activity was observed in senescent HDFs while the levels of damaged DNA and number of cells in G(0)/G(1) phase were increased and S phase cells were decreased. Incubation with TRF reversed the morphology of senescent HDFs to resemble that of young cells with decreased activity of SA-β-gal, damaged DNA, and cells in G(0)/G(1) phase while cells in the S phase were increased. Elongated telomere length and restoration of telomerase activity were observed in TRF-treated senescent HDFs. These findings confirmed the ability of tocotrienol-rich fraction in preventing HDFs cellular ageing by restoring telomere length and telomerase activity, reducing damaged DNA, and reversing cell cycle arrest associated with senescence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Cycle / drug effects*
  • Cell Shape / drug effects
  • Cells, Cultured
  • Cellular Senescence / drug effects*
  • Chemical Fractionation
  • Comet Assay
  • DNA Damage
  • Diploidy*
  • Fibroblasts / cytology*
  • Fibroblasts / drug effects
  • Fibroblasts / enzymology
  • Fibroblasts / metabolism*
  • Humans
  • Staining and Labeling
  • Telomerase / metabolism
  • Telomere / metabolism*
  • Tocotrienols / pharmacology*
  • beta-Galactosidase / metabolism

Substances

  • Tocotrienols
  • Telomerase
  • beta-Galactosidase